Neoplàsia endocrina múltiple (Catalan Wikipedia)

Analysis of information sources in references of the Wikipedia article "Neoplàsia endocrina múltiple" in Catalan language version.

refsWebsite

Global rank Catalan rank

2^nd place

6^th place

4^th place

7^th place

6^th place

29^th place

low place

1^st place

234^th place

127^th place

2,569^th place

409^th place

archive.org

Asgharian, B; Turner, ML; Gibril, F; Entsuah, LK; Serrano, J «Cutaneous tumors in patients with multiple endocrine neoplasm type 1 (MEN1) and gastrinomas: prospective study of frequency and development of criteria with high sensitivity and specificity for MEN1.». The Journal of Clinical Endocrinology and Metabolism, 89, 11, 11-2004, pàg. 5328–36. DOI: 10.1210/jc.2004-0218. PMID: 15531478.
«Pancreatitis as the first manifestation of multiple endocrine neoplasia type 2A». Arq Bras Endocrinol Metabol, 52, 8, 11-2008, pàg. 1332–6. DOI: 10.1590/S0004-27302008000800021. PMID: 19169490.
«Multiple endocrine neoplasia type 2: An overview». Genetics in Medicine, 13, 9, 2011, pàg. 755–764. DOI: 10.1097/GIM.0b013e318216cc6d. PMID: 21552134.
Wermer P «Genetic aspects of adenomatosis of endocrine glands». Am. J. Med., 16, 3, 1954, pàg. 363–71. DOI: 10.1016/0002-9343(54)90353-8. PMID: 13138607.
Sipple JH «The association of pheochromocytoma with carcinoma of the thyroid gland». Am. J. Med., 31, 1961, pàg. 163–6. DOI: 10.1016/0002-9343(61)90234-0.

[1] Arxivat 2017-03-14 a Wayback Machine. 123I labeled metaiodobenzylguanidine for diagnosis of neuroendocrine tumors. Jiang L, Schipper ML, Li P, Cheng Z, Reports in Medical Imaging. 2009: 2 79-89

Asgharian, B; Turner, ML; Gibril, F; Entsuah, LK; Serrano, J «Cutaneous tumors in patients with multiple endocrine neoplasm type 1 (MEN1) and gastrinomas: prospective study of frequency and development of criteria with high sensitivity and specificity for MEN1.». The Journal of Clinical Endocrinology and Metabolism, 89, 11, 11-2004, pàg. 5328–36. DOI: 10.1210/jc.2004-0218. PMID: 15531478.
«Pancreatitis as the first manifestation of multiple endocrine neoplasia type 2A». Arq Bras Endocrinol Metabol, 52, 8, 11-2008, pàg. 1332–6. DOI: 10.1590/S0004-27302008000800021. PMID: 19169490.
«Multiple endocrine neoplasia type 2: An overview». Genetics in Medicine, 13, 9, 2011, pàg. 755–764. DOI: 10.1097/GIM.0b013e318216cc6d. PMID: 21552134.
Wermer P «Genetic aspects of adenomatosis of endocrine glands». Am. J. Med., 16, 3, 1954, pàg. 363–71. DOI: 10.1016/0002-9343(54)90353-8. PMID: 13138607.

Martino Ruggieri. Neurocutaneous Disorders : The Phakomatoses. Berlin: Springer, 2005. ISBN 978-3-211-21396-4. - Chapter: Multiple Endocrine Neoplasia Type 2B by Electron Kebebew, Jessica E. Gosnell and Emily Reiff. Pages 695-701. [2]^{[Enllaç no actiu]} This reference quotes a prevalence of 1 in 40,000, but this figure is inconsistent with the same reference's calculated incidence of 4 per 100 million per year for MEN2B.

[1] Arxivat 2017-03-14 a Wayback Machine. 123I labeled metaiodobenzylguanidine for diagnosis of neuroendocrine tumors. Jiang L, Schipper ML, Li P, Cheng Z, Reports in Medical Imaging. 2009: 2 79-89